Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
Fumery M, Defrance A, Roblin X, Altwegg R, Caron B, Hébuterne X, Stefanescu C, Meyer A, Nachury M, Laharie D, Nancey S, Le Berre C, Serrero M, Geyl S, Giletta C, Ah-Soune P, Duveau N, Uzzan M, Abitbol V, Biron A, Tran-Minh ML, Paupard T, Vuitton L, Elgharabawy Y, Peyrin-Biroulet L.
Fumery M, et al. Among authors: paupard t.
Aliment Pharmacol Ther. 2023 Feb;57(4):426-434. doi: 10.1111/apt.17358. Epub 2022 Dec 19.
Aliment Pharmacol Ther. 2023.
PMID: 36534763